about
Comparison of Drug-Eluting Balloon Followed by Bare Metal Stent with Drug-Eluting Stent for Treatment of de Novo Lesions: Randomized, Controlled, Single-Center Clinical Trial.The effect of admission at weekends on clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome and its contributing factors.Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.Relation of Renal Function with Left Ventricular Systolic Function and NT-proBNP Level and Its Prognostic Implication in Heart Failure with Preserved versus Reduced Ejection Fraction: an analysis from the Korean Heart Failure (KorHF) Registry.Impact of Heart Rate Reduction with Maximal Tolerable Dose of Bisoprolol on Left Ventricular Reverse Remodeling.S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.KSHF Guidelines for the Management of Acute Heart Failure: Part II. Treatment of Acute Heart FailureKSHF Guidelines for the Management of Acute Heart Failure: Part I. Definition, Epidemiology and Diagnosis of Acute Heart FailureKSHF Guidelines for the Management of Acute Heart Failure: Part III. Specific Management of Acute Heart Failure According to the Etiology and Co-morbidityPrognostic Effect of Guideline-Directed Therapy Is More Noticeable Early in the Course of Heart FailureBeta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction: Results from The Korea Acute Heart Failure (KorAHF) Registry.Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a cohort studyFactors Associated with Low Awareness of Heart Failure in the General Population of KoreaCharacteristics and outcomes of HFpEF with declining ejection fractionArtificial intelligence for the diagnosis of heart failureClopidogrel versus Aspirin after Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients Undergoing Drug-Eluting StentingLong-Term Safety of a Novel Angiotensin Receptor Blocker, Fimasartan, According to the Absence or Presence of Underlying Liver Disease in Korean Hypertensive Patients: A Prospective, 12-Month, Observational StudyEffect of Hyperglycemia on Myocardial Perfusion in Diabetic Porcine Models and HumansPrognostic Implication of Ventricular Conduction Disturbance Pattern in Hospitalized Patients with Acute Heart Failure SyndromeGuideline-directed therapy at discharge in patients with heart failure and atrial fibrillationImpact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction
P50
Q33661362-9B12CD57-4D51-4A60-AD33-F2944B3B2390Q34469652-7702451B-C1FE-4E61-AE79-31A031FA4E4AQ41686228-EBAC15D6-6ACE-42F2-ACA6-6681AEE8BD00Q41686272-08104594-53D5-4741-85DC-04EDEA770CE2Q55309021-52354CB4-5374-46D3-9A83-348A4344ADBCQ55312135-6B5D2AE1-7117-439B-A5B8-F9FBED06BA13Q60931782-3930464D-55FA-42EE-BF68-8A7B2571ACEEQ60931790-ED0AC68A-14E9-49FD-866D-9578C6B8F126Q60935054-14B758CC-3FA8-4FDD-ACA7-29827836B580Q64094704-98F66D9E-0297-45F1-B64B-B26E2054FEAFQ64930053-FB0DAD85-496F-49BC-B1CC-3DB3586A3C16Q89601140-D7435B7B-DB96-4C27-AFE3-01BD96E6A7DEQ90651437-C8FD0814-2B8A-4C4E-ADE0-F9D2C9DF7583Q91566852-2C1E2A74-70E9-4B74-AD36-7CE8A1977DC7Q91879091-EAF1DD47-DA44-4226-8BE3-6DCC9944571BQ92036739-37FF113F-1AB0-4723-A932-0F56FFC0D287Q92059736-5C815BA8-85A4-4CAB-A6BE-0C0F28F28263Q92195530-D5D76425-A95A-4B1A-8407-11467F1D56B7Q92496019-7ACB4E33-4D68-4038-A29D-800DFF82AF3EQ93160912-34203D61-FB94-499C-AF6B-74E2E0E64A73Q93268250-049D8C06-6BD9-41A1-B82D-9974962BBEAB
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Dong-Ju Choi
@en
Dong-Ju Choi
@nl
type
label
Dong-Ju Choi
@en
Dong-Ju Choi
@nl
prefLabel
Dong-Ju Choi
@en
Dong-Ju Choi
@nl
P31
P496
0000-0003-0146-2189